Metagenomi Therapeutics, Inc. (MGX)
NASDAQ: MGX · Real-Time Price · USD
1.205
-0.015 (-1.23%)
At close: Jul 24, 2026, 4:00 PM EDT
1.200
-0.005 (-0.41%)
After-hours: Jul 24, 2026, 7:11 PM EDT
Metagenomi Therapeutics Stock Forecast
Stock Price Forecast
According to 5 analysts polled by S&P Global, Metagenomi Therapeutics stock has a consensus rating of "Strong Buy" and an average price target of $7.67. The average 1-year stock price forecast is 536.51% higher than the current stock price, while the lowest is $5.00 (+314.94%) and the highest is $9.00 (+646.89%).
Price Target: $7.67 (+536.51%)
Analyst Consensus: Strong Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for Metagenomi Therapeutics stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Jan '26 | Feb '26 | Mar '26 | Apr '26 | May '26 | Jul '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 4 | 4 | 4 | 4 | 3 | 4 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 1 | 1 | 1 | 1 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 5 | 5 | 5 | 5 | 4 | 5 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Chardan Capital | Chardan Capital | Buy Maintains $5 | Buy | Maintains | $5 | +314.94% | Jul 7, 2026 |
| Wells Fargo | Wells Fargo | Buy Maintains $12 → $9 | Buy | Maintains | $12 → $9 | +646.89% | May 12, 2026 |
| TD Cowen | TD Cowen | Buy Maintains n/a | Buy | Maintains | n/a | n/a | May 11, 2026 |
Financial Forecast
Revenue This Year
10.25M
from 25.21M
Decreased by -59.35%
Revenue Next Year
11.15M
from 10.25M
Increased by 8.84%
EPS This Year
-2.16
from -2.36
EPS Next Year
-2.12
from -2.16
EPS and Forward PE are based on non-GAAP adjusted numbers.